Galera Therapeutics, Inc.
GRTX
$0.0235
-$0.0004-1.67%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -4.93M | -5.58M | -4.06M | -4.38M | -5.59M |
| Total Depreciation and Amortization | 0.00 | 5.00K | 6.00K | 9.00K | 215.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.79M | 3.54M | 723.00K | 875.00K | 1.89M |
| Change in Net Operating Assets | -1.20M | -257.00K | 618.00K | -1.29M | -6.44M |
| Cash from Operations | -2.34M | -2.30M | -2.72M | -4.79M | -9.92M |
| Capital Expenditure | -- | -- | -- | -- | -9.00K |
| Sale of Property, Plant, and Equipment | 0.00 | 4.00K | -- | -- | -- |
| Cash Acquisitions | -50.00K | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 3.98M |
| Cash from Investing | -50.00K | 4.00K | -- | -- | 3.98M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2.22M | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -2.64M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 2.40M |
| Cash from Financing | 2.22M | -- | -- | -- | -232.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -166.00K | -2.29M | -2.72M | -4.79M | -6.17M |